Objective: To assess the association of proxies of behavioral adherence to the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) lifestyle program with changes in glycemic control and obesity in a multi-ethnic sample of youth with type 2 diabetes.
| INTRODUCTION
In response to increases in the prevalence of type 2 diabetes in children and adolescents, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) funded the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) randomized clinical trial, which compared the efficacy of 3 treatment arms: metformin monotherapy, metformin plus rosiglitazone, and metformin plus an intensive lifestyle intervention. After following the cohort for an average of 3.86 years, the trial found that the addition of rosiglitazone but not lifestyle intervention was associated with durable glycemic control. 1 The metformin plus intensive lifestyle intervention was associated with superior short-term weight loss when compared to metformin monotherapy or metformin plus rosiglitazone, but contrary to expectation, this favorable change was not associated with durable glycemic control.
However, a secondary analysis of data from the TODAY cohort (irrespective of randomized treatment) confirmed a relation between changes in weight and cardiovascular risk factors over time, suggesting the importance of weight management in youth with type 2 diabetes. 2 Findings in the pediatric obesity literature have documented a relationship between proxies for lifestyle program adherence, such as session attendance and compliance with self-monitoring of food intake and physical activity, and program outcomes. Higher levels of session attendance have been shown to be related to greater decreases in child percent overweight. [3] [4] [5] Self-monitoring also has been shown to be associated with successful weight management in adolescents with obesity 6 and minority youth with severe obesity. 7 Further, there is some evidence that parent self-monitoring is related to short-term weight losses among adolescents. 8 In TODAY, attendance at a pre-planned target of at least 75% of lifestyle program sessions during the first 24 months of the program was not associated with longer-term weight loss or maintenance of glycemic control. 1 Given the imperative to enhance the effectiveness of treatments for pediatric type 2 diabetes 9 and initial findings documenting an association between weight changes and risk factor status, 2 there is a strong rationale for examining more closely the role of adherence in the intensive lifestyle intervention in TODAY.
In the current analysis, we report on 2 proxies for adherence to the TODAY lifestyle program (TLP), session attendance and selfmonitoring of food intake and physical activity, and their association with changes in measures of obesity and glycemic control in a multiethnic sample of youth. We hypothesized that attendance at lifestyle intervention sessions and higher frequency of self-monitoring in youth and family participants would be positively associated with treatment outcome. We also examined whether baseline characteristics were related to or predictive of program adherence.
| RESEARCH DESIGN AND METHODS

| TODAY study design
Design of the TODAY clinical trial has been reported. 10 
| Lifestyle program elements
Details of the TLP have been described. 11 The program was designed to incorporate evidence-supported components used in numerous studies of family-based pediatric obesity treatment 12, 13 and was conducted separately from the medical management provided to all TODAY participants. The program was administered in 3 consecutive phases. In phase 1, lifestyle change (LC) was delivered over the first 6 to 8 months in weekly sessions focused on achieving weight loss, physical activity, and behavior change goals. Lessons followed a set curriculum to ensure that a standard intervention was delivered.
Weekly in-person sessions were held at the clinic, home, community location, or via telemedicine. A weight loss goal of 1 pound/week was encouraged and incentives were provided based on the attainment of goals. In phase 2, lifestyle maintenance (LM) was delivered during in-person sessions scheduled every 2 weeks for 6 to 8 months and phone contact with the participant in the intervening week; the purpose was to continue to reinforce and review the concepts introduced in LC. In the continuing contact (CC) phase 3, the youth The lifestyle program was designed to be administered in 2 years, the minimum duration of follow-up in TODAY. Participants with follow-up greater than 2 years were considered to be in "extended" CC and continued to meet quarterly with their PAL until the end of the study. The current paper reports on activities during the first 2 years only.
| Proxies for program adherence
Adherence to the lifestyle program was defined by session attendance and self-monitoring of diet and physical activity (keeping a recorded log) by the youth participant and family member.
| Attendance
Per protocol, a session included face-to-face contact at the clinic, a community location, the home, or via telemedicine. The LC phase was designed to be delivered in 24 weekly sessions; participants were given up to 8 months to complete the phase to accommodate missed sessions, so actual number of weeks in LC could exceed 24. The LM phase included 1 session biweekly for 6 months, for a total of 12 inperson sessions; participants were given up to 8 months to complete the phase. The CC phase was 1 session per month for 12 months, for a total of 12 in-person sessions.
| Self-monitoring of diet and physical activity
Participants were instructed to self-monitor by recording targeted diet modification and physical activity behaviors in lifestyle logs between sessions and to bring the logs to each session. Diet modification involved self-monitoring "red" (or "stop and think") foods containing 5 or more grams of fat, sugary cereals, energy-dense, non-nutritious snacks, and soft drinks. Participants were considered adherent to selfmonitoring of diet if they had recorded red foods on at least 1 day during the period since the last session. Physical activity targets of minutes per week of moderate-to-vigorous intensity activity were set for participants and minutes per day were entered into the log; adherence to self-monitoring was defined as at least 1 day of activity minutes recorded in the log. Adherence to self-monitoring of red foods and activity were calculated as number of times the participant met adherence criteria across sessions for each program phase.
| Family member self-monitoring
The family member supporting the participant was also directed to self-monitor using a lifestyle log; adherence was defined as having made at least 1 entry for one of the target behaviors in the log between sessions.
| Measurement of adherence
Adherence to lifestyle treatment was expressed by phase as the percent of the session target goal accomplished for each of the 4 measures (participant session attendance, participant self-monitoring logs of red foods and physical activity, and self-monitoring by a family member). Only sessions that occurred before study endpoint (occurrence of treatment failure or end of protocol participation) were included. Session attendance was dichotomized using a cut-off of 75% (<75% vs ≥75%), the same criterion used to monitor adequacy of attendance during the trial. For intent-to-treat purposes, a participant was assigned counts of zero for measures of attendance in a phase if no sessions were documented, but date of study endpoint was after the anticipated time period for the phase; for example, a participant could be a "no-show" for LM but return months later to be placed in CC without experiencing study endpoint, and counts of zero were given for adherence measures during LM.
| Baseline characteristics
Race-ethnicity was determined by self-report on 2 separate items; categories that were too small for separate analysis were combined into "other." Tanner stage was evaluated by physical examination of breasts and pubic hair for girls and genitalia and pubic hair for boys. (n = 111), and in the 155 who started CC phase comparing those with ≥75% in all 3 phases LC, LM, and CC (n = 43) vs <75%
(n = 112). Adequate adherence to study medication (dose taken ≥80% by pill count) was tested as a covariate, but was not significantly related to program adherence (P = .4374 in LC phase) and was dropped. Survival analysis tested for differences in time to primary outcome in those who started LM phase, comparing those who had <75% LC phase session adherence to those who had ≥75%. Longitudinal analysis used general linear mixed models to account for the repeated measures. All results are considered exploratory and P < .05
is considered statistically significant without adjustment for multiple comparisons; the study was powered for the primary outcome only.
| RESULTS
Of 699 eligible participants in the TODAY cohort, 234 were randomized to M + L. (7) while in LM, leaving 155 who started CC phase. Figure 1 shows mean percent for each of the 4 adherence metrics.
| Measures of adherence proxies by program phase
Average session attendance in LC was 65%, LM 70%, and CC 57%.
Within each phase, session attendance rates were much higher than the other metrics of adherence; self-monitoring by either the participant or family member occurred in less than half the sessions attended. In LM and CC phases, participant self-monitoring of red foods and physical activity were at similar levels, but the frequency of family member self-monitoring was about half that of youth partici- 
| Session attendance and treatment failure
To test for an effect of session attendance on subsequent treatment failure (loss of glycemic control), the analysis was performed on the 187 participants who started the LM phase; those who did not start LM either failed or dropped out prior to having the opportunity to achieve ≥75% attendance. Of the 98 with ≥75% session attendance in the LC phase, 39.8% failed to maintain glycemic control vs 33.7% of the 89 with <75% (P = .3889). Survival analysis showed no difference in time to treatment failure in those who did vs those who did not achieve adequate session adherence in the LC phase (P = .4263).
The analysis was repeated for the 155 participants who started the CC program phase, that is, had complete session adherence data for both LC and LM phases. Of the 73 who achieved ≥75% session attendance in both LC and LM phases, 26.0% failed to maintain glycemic control vs 30.5% of the 82 who had <75% in 1 or both phases (P = .5387).
| Session attendance and weight change
Percent overweight was used to test for an effect of session attendance on change in weight. Figure 2 shows mean change from baseline in percent overweight for participants who had <75% LC phase session attendance vs ≥75%. There was a significant difference between the groups (P = .0026) that occurred by month 6 and persisted without a trend over time (ie, the lines were flat and parallel). Table 1 compares baseline demographics and characteristics in participants who had <75% LC phase session attendance vs ≥75%. Characteristics that were not significant in LC phase were not significant in either of the other analyses that looked at consistently high adherence in LC + LM and in LC + LM + CC. Of the 4 characteristics that were significantly different in LC phase-sex (P = .0248), living with biological parents (.0032), presence of depressive symptoms in adult caregiver (P = .0347), and length of pre-randomization run-in period (P = .0007)-only sex and living with biological parents maintained statistical significance across all 3 comparisons. Males were more likely to achieve higher levels of session adherence; 37.9% of males consistently attended ≥75% of sessions across LC, LM, and CC phases compared to 21.6% of females (P = .0285). Participants with ≥75% session attendance were more likely to be living with both biological parents and participants with <75% session attendance were more likely to be living with the biological mother but not father.
| Baseline characteristics associated with session attendance
| CONCLUSIONS
In the TODAY randomized clinical trial, the intensive family-based lifestyle program added to metformin was associated with greater short-term decreases in percent overweight but not the maintenance of glycemic control in youth with type 2 diabetes compared with youth treated with metformin monotherapy. 1 The present analysis Change is calculated as the difference between follow-up minus baseline (negative indicates a decrease from baseline). Means are plotted across study month (session) by LC phase session attendance < or ≥75%. The 2 lines are significantly different (P = .0056) and parallel (interaction with study month not significant), for example, difference at 6 months was sustained examined 2 proxies of adherence to the lifestyle programattendance at intervention contacts and self-monitoring-in order to understand more fully the outcomes associated with the lifestyle program. Findings confirmed that session attendance was moderately high as further described below and was related to weight loss, but rates of self-monitoring were poor and insufficient for additional analysis.
Session attendance has been used in several pediatric obesity trials as a proxy for program adherence.
3 Self-monitoring of food and, to a lesser extent physical activity, is a key aspect of behavioral weight management in adults, 19 and self-monitoring frequency has been shown to be associated with short-and long-term weight loss in adults 20 and children. 6 The dose of self-monitoring required for success, however, is not clear. 21 Nevertheless, the dose of self-monitoring by youth in TODAY was lower than that observed in other youth weight management studies and reasons for low rates of self-monitoring adoption are not clear. Low rates might be associated with numerous methodological factors that affect the reliability and validity of behavioral interventions. 22 In TODAY, study design, PAL training, lifestyle intervention delivery, and participant characteristics are just a few of the factors that could have affected whether youth understood and were able to perform self-monitoring correctly. We do not have the data to evaluate most aspects of treatment fidelity, but it is possible that despite intensive PAL training and supervision, there was insufficient emphasis on barriers to self-monitoring or the importance of 
